Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
On Jan. 20, 2005, the Siteman Cancer Center received National Cancer Institute (NCI) designation as a Comprehensive Cancer…
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
On Sept. 3, 2003, the death rates from the four most common cancersï¾—lung, breast, prostate, and colorectalï¾—continued to…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
On Dec. 12, 2002, a National Cancer Institute announced that a clinical trial had shown that reducing the…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…